Blake Wise
Director/Board Member chez CALITHERA BIOSCIENCES, INC.
Fortune : - $ au 31/03/2024
Profil
Mr. Blake Wise is a Chief Executive Officer & Director at Novome Biotechnologies, Inc. and an Independent Director at Calithera Biosciences, Inc. He is on the Board of Directors at Novome Biotechnologies, Inc. and Calithera Biosciences, Inc. Mr. Wise was previously employed as a Chief Executive Officer & Director by Achaogen, Inc. and a Senior Director by Genentech, Inc. He received his undergraduate degree from the University of California, Santa Barbara and an MBA from Haas School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/04/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Blake Wise
| Sociétés | Poste | Début |
|---|---|---|
| CALITHERA BIOSCIENCES, INC. | Director/Board Member | 21/09/2017 |
Novome Biotechnologies, Inc.
 Novome Biotechnologies, Inc. BiotechnologyHealth Technology Novome Biotechnologies, Inc. operates as a biotechnology company focused on engineering defined activities into the human gut microbiota to treat chronic diseases. The company was founded by William DeLoache, Weston Whitaker, Liz Shepherd and Zachary Russ in 2016 and is headquartered in South San Francisco, CA. | Chief Executive Officer | 01/12/2019 |
Anciens postes connus de Blake Wise
| Sociétés | Poste | Fin |
|---|---|---|
| ACHAOGEN | Chief Executive Officer | 01/12/2019 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
Formation de Blake Wise
| University of California, Santa Barbara | Undergraduate Degree |
| Haas School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CALITHERA BIOSCIENCES, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA. | Health Technology |
Novome Biotechnologies, Inc.
Novome Biotechnologies, Inc. BiotechnologyHealth Technology Novome Biotechnologies, Inc. operates as a biotechnology company focused on engineering defined activities into the human gut microbiota to treat chronic diseases. The company was founded by William DeLoache, Weston Whitaker, Liz Shepherd and Zachary Russ in 2016 and is headquartered in South San Francisco, CA. | Health Technology |
